IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis
Theranostics · 2024 · 14 (6) · 2605-2621
DOI: 10.7150/thno.92672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Sri Murugan Poongkavithai Vadevoo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic …. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, HMGB1 Protein, Reactive Oxygen Species, Macrophages. Die Arbeit wurde bisher 54-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.
- Department of Biomedical Science, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.
- CMRI, School of Medicine, Kyungpook National University, 680 Gukchaebosang-ro, Jung-gu, Daegu 41944, Republic of Korea.
- Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), 77 Cheongam-ro, Nam-gu, Pohang, Gyeongbuk 37673, Republic of Korea.
- Laboratory Animal Center, K-Medi Hub, 88 Dongnae-ro, Dong-gu, Daegu 41061, Republic of Korea.
- Laboratory Animal Research Facility, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Koyang, Kyunggi 10408, Republic of Korea.
Zitieren
APA
Vadevoo, S. M. P., Kang, Y., Gunassekaran, G. R., Lee, S. M., Park, M. S., Jo, D. G., Kim, S. K., Lee, H., Kim, W. J., & Lee, B. (2024). IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis. Theranostics, 14(6), 2605-2621. https://doi.org/10.7150/thno.92672
Vancouver
Vadevoo SMP, Kang Y, Gunassekaran GR, Lee SM, Park MS, Jo DG, et al. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis. Theranostics. 2024;14(6):2605-2621. doi:10.7150/thno.92672
BibTeX
@article{Vadevoo2024,
author = {Vadevoo, Sri Murugan Poongkavithai and Kang, Yeoul and Gunassekaran, Gowri Rangaswamy and Lee, Seok-Min and Park, Min-Sung and Jo, Dong Gyun and Kim, Sang-Kyun and Lee, Ho and Kim, Won Jong and Lee, Byungheon},
title = {IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {6},
pages = {2605--2621},
doi = {10.7150/thno.92672}
}
EUVIMED